...
首页> 外文期刊>Orthopaedic surgery >Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study
【24h】

Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study

机译:四肢骨巨细胞肿瘤治疗施用和辅助微波治疗的新策略:初步研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives To evaluate whether curettage with adjuvant microwave therapy was successful in the treatment of giant cell tumor of the bone (GCTB) in extremities, especially for GCTB with pathological fractures and GCTB of the distal radius. Methods This was a retrospective study of 54 cases of GCTB of the extremities treated by curettage with adjuvant microwave therapy between 2007 and 2019. Five patients were lost to follow up and excluded from the study. A total of 33 male and 21 female patients were included in this study. Patients were aged 15–57?years (mean 29.72?±?10.48?years). Among these patients, there were 10 cases of GCTB with pathological fractures and eight cases of GCTB of the distal radius; one of these cases was combined with a pathological fracture. Comprehensive imaging examinations (X‐rays [including lesion site and chest], CT, MRI, emission computed tomography, and pathology examination) of all patients were reviewed. The clinical staging of these patients were evaluated radiologically using the Campanacci classification system based on the extent of spread of the tumor. All patients underwent curettage with adjuvant microwave therapy. Clinical and imaging evaluations were performed in all cases to check for recurrence or metastasis. Lower limb and upper limber function were assessed using the Musculoskeletal Tumor Society score (MSTS), and wrist function was assessed according to the disabilities of the arm, shoulder and hand (DASH) score. Data on surgical‐related complications were recorded. Results All cases were followed up for 24–126?months (mean 60.69?±?29.61?months). There were 24 patients with a Campanacci grade of 3 and 30 with a Campanacci grade of 2. The 52 patients were continuously disease‐free. The local recurrence rate was 3.70% (2 patients). One patient had recurrence in the proximal femur, and the other developed in soft tissue of the calf muscle. No recurrence occurred for GCTB of the distal radius. One recurrence occurred in a GCTB with pathological fractures. The intervals were 9 and 28?months, respectively. The cases of recurrence all had a Campanacci grade of 3 (8.33%). The median MSTS among the 54?patients was 27.67?±?3.81. The mean wrist function DASH score was 8.30?±?2.53. The mean MSTS was 28.67?±?1.63 and 26.71?±?5.49 for patients with GCTB of the distal radius and for those with pathological fractures, respectively. In comparing patients with and without pathological fractures, there was no significant difference in the MSTS functional score. Five patients had complications after the surgery. Conclusion Curettage with adjuvant microwave ablation therapy provided favorable local control and satisfactory functional outcomes in the treatment of GCTB, especially for cases with pathological fractures and those with GCTB of the distal radius.
机译:目的是评估辅助微波疗法的刮痕是否成功地治疗骨骼(GCTB)的骨髓肿瘤,特别是对于具有病理骨折和远端半径的GCTB的GCTB。方法这是对2007年至2019年施用微波治疗的施用微波治疗54例GCTB的回顾性研究。五名患者失去了跟进并被排除在研究之外。本研究共有33名男性和21例女性患者。患者年龄15-57岁?年(平均29.72?±10.48岁)。在这些患者中,有10例GCTB,病理骨折和远端半径的8例GCTB;其中一种情况与病理骨折相结合。综述(X射线[包括病变部位和胸部],CT,MRI,排放计算断层扫描和病理检查)进行了审查。基于肿瘤的蔓延的范围,通过CAMPANCCI分类系统进行放射性地评估这些患者的临床分期。所有患者均接受弯曲的微波疗法。在所有情况下进行临床和成像评估以检查复发或转移。使用肌肉骨骼肿瘤协会评分(MSTS)评估下肢和上肢功能,并根据手臂,肩部和手(仪表手)得分的障碍进行评估。记录了与外科医生相关的复杂性的数据。结果所有病例均出现24-126?月份(平均60.69?±29.61个月)。有24名Campanacci等级3和30名患者,坎帕契等级为2. 52名患者不断无疾病。局部复发率为3.70%(2名患者)。一名患者在近端股骨中复发,另一个患者在小腿肌肉的软组织中发育。远端半径的GCTB没有发生复发。一种复发发生在具有病理骨折的GCTB中。间隔分别为9和28个月。复发的案例所有人的坎帕契等级为3(8.33%)。 54中的中位数MSTS?患者是27.67?±3.81。平均腕部功能损坏得分为8.30?±2.5​​3。平均MSTS分别为28.67?±1.63和26.71?±5.49分别为远端半径的GCTB和具有病理骨折的患者。在将患者与病变骨折的比较时,MSTS功能得分无显着差异。手术后五名患者在并发症。结论具有佐剂微波消融治疗的乳化术提供了有利的局部控制和令人满意的功能结果,特别是对于病理骨折的病例和远端半径的GCTB的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号